SCHEMBL5124396

SCHEMBL5124396

O=C1NC(c2ccccc2)=C2C(=O)N(c3ccccc3)C(c3ccccc3)=C12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRK5 P34947 1/20 0.42
TYRO3 Q06418 1/20 0.42
DYRK1B Q9Y463 1/20 0.42
ITGA4 P13612 2/20 0.38
ITGB7 P26010 2/20 0.38
PTGS2 P35354 2/20 0.37
PTPN1 P18031 1/20 0.37
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
NR1H2 P55055 1/20 0.35
NR1H3 Q13133 1/20 0.35
MGLL Q99685 2/20 0.35
ALDH1A1 P00352 2/20 0.35
FAAH O00519 1/20 0.35
GSK3B P49841 1/20 0.35
KDM4E B2RXH2 2/20 0.35
LMNA P02545 2/20 0.35
MAPT P10636 2/20 0.35
PKM P14618 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5068959 0.81 MGLL (0.46) GRK5TYRO3DYRK1BMEN1KMT2A
SCHEMBL27575223 0.79 NR1H2 (0.45) GRK5TYRO3DYRK1BMEN1KMT2A
SCHEMBL6693898 0.79 PTGS2 (0.45) PTGS2NR1H2NR1H3GSK3B
SCHEMBL21419681 0.79 GSK3B (0.36) GRK5TYRO3DYRK1BPTGS2MEN1
SCHEMBL19304186 0.79 PTGS2 (0.37) GRK5TYRO3DYRK1BPTGS2MEN1
SCHEMBL13883926 0.78 PTGS2 (0.44) PTGS2NR1H2NR1H3GSK3B
SCHEMBL8801436 0.76 PTGS2 (0.36) PTGS2MEN1KMT2ANR1H2NR1H3
SCHEMBL278635 0.75 GSK3B (0.48) PTGS2ALDH1A1GSK3BKDM4ELMNA
SCHEMBL3265789 0.75 PTGS2 (0.37) PTGS2ALDH1A1GSK3B
SCHEMBL8759244 0.74 GSK3B (0.43) PTGS2NR1H2NR1H3GSK3BLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7442804-B2 Process for the preparation of furopyrroles CIBA SPECIALTY CHEMICALS CORPORATION (US) 2008-10-28 US disclosed
US-7442804-B2 Process for the preparation of furopyrroles CIBA SPECIALTY CHEMICALS CORPORATION (US) 2008-10-28 US disclosed
US-7442804-B2 Process for the preparation of furopyrroles CIBA SPECIALTY CHEMICALS CORPORATION (US) 2008-10-28 US disclosed
US-20070100135-A1 Process for the preparation of furopyrroles CIBA SPECIALTY CHEMICALS CORPORATION 2007-05-03 US disclosed
US-20070100135-A1 Process for the preparation of furopyrroles CIBA SPECIALTY CHEMICALS CORPORATION 2007-05-03 US disclosed
US-20070100135-A1 Process for the preparation of furopyrroles CIBA SPECIALTY CHEMICALS CORPORATION 2007-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070100135-A1 Process for the preparation of furopyrroles CCND3, C1S, CCNL2 GRK5 398/4885TYRO3 58/4885DYRK1B 385/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.